Abstract:In this work, we reported four new copper(II) halo-benzoate complexes (2-chloro-4-nitrobenzoate (2-Cl-4-NO2-BZ), 3,5-DICBZ, 2-chloro-5-nitrobenzoate (2-Cl-5-NO2-BZ), 3,5-difluoro benzoate (3,5-DIFBZ), and 3,5-dichlorobenzene (3,5-DICBZ) respectively in complexes 1–4 ) with N,N,N',N'- tetramethylethylene diamine ( temed ) N-donor ligand in order to study the interesting coordination features and biological evaluation of such complexes under ambient reaction conditions. All the complexes 1–4 were characterized by elemental analyses, and spectroscopic techniques, including FT-IR, UV–vis, and EPR etc. Single crystal X-ray structure determination (SCXRD) of complexes revealed the distorted octahedral geometry in all complexes. Notably, the halobenzoate ligands exhibited a bidentate chelation mode in complexes 1 and 2 , while they showed a monodentate mode in complex 3 . In complex 4 , the carboxylate ligand exhibited both monodentate as well as bidentate coordination. Furthermore, detailed packing analyses of complexes 1–4 highlighted the significance of halogen bonding in lattice stabilization besides hydrogen bonding and π∙∙∙π interactions as evidenced by Hirshfeld surface analyses and crystal analysis. Moreover, packing analyses displayed that complex 1 exhibited a layered or wave-like arrangement, while complex 2 featured a helical arrangement supported by a supramolecular halogen-bonded network guided by Cl∙∙∙O interactions. Complex 3 displayed a zig-zag layered arrangement with a stacking topology, and Complex 4 showcased a ribbon-like arrangement stabilized by F∙∙∙F and Cl∙∙∙Cl halogen bonding interactions. Furthermore, sigma hole on halogen atoms has also been examined (which play an important role in halogen bonding) by electrostatic-potential isosurfaces. In order to exploit the biological efficacy of complexes 1–4 owing to the inherent biological activity of copper metal, molecular docking analyses against gram +ve bacteria i.e. S. epidermidis (PDB ID; 8DO6), B. subtilis (1QD9), as well as two gram -ve bacteria, namely, P. aeruginosa (5WZE) and S. dysenteriae (1DM0), have also been carried out. Interestingly, values of docking scores and inhibition constant of all complexes 1–4 (with a maximum binding score (inhibition constant) of -9.8 kcal/mol (0.063 μMol) in 1 against 8DO6 and 1DM0) revealed higher biological efficacy than that of standard drugs.

Structural manifestations and biological screening for newly synthesized heteroleptic bismuth(V) bis-carboxylates

ANTITUMOR AND GASTROPROTECTIVE SCREENING OF SOME NOVEL ORGANIC DERIVATIVES OF BISMUTH

Structure elucidation {single X-ray crystal diffraction studies, Hirshfeld surface analysis, DFT} and antibacterial studies of 1,2-benzothiazine metal complexes

Bismuth(III) bromide-thioamide complexes: synthesis, characterization and cytotoxic properties

Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal(II) complexes derived from heterocyclic Schiff base ligands

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Design, synthesis, and biological evaluation of dinuclear bismuth(III) complexes with Isoniazid-derived Schiff bases

Structural consequences in differently substituted haloarylcarboxylates and non-covalent interactions on crystal packing and biological efficacy of copper(II) complexes with N,N,N′,N′-tetramethylethylenediamine N-donor ligand

Synthesis, DFT, Molecular Docking, and Antimicrobial Studies of New Indole-Thiosemicarbazone Ligand and Their Complexes with Fe(III), Co(II), Ni(II), Cu(II)

Antibacterial performance of heterocyclic organobismuth (III) complexes based on bidentate C,O‐coordinating ligands: Synergism of ligand identity and coordination number

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Novel Schiff base (E)-2-((4-chloro-3-nitrophenylimino)(phenyl)methyl)-5-methoxyphenol and Mixed Ligand Complexes of Mn(II), Fe(III), Co(II), Ni(II) and Cu(II): synthesis, structure elucidation and potency study as antibacterial, antimalarial, antioxidant, antidibetic and anticancer agents

Synthesis, Characterization, Geometric Optimization and Multi-Target Therapeutic Evaluation of New Homoleptic and Heteroleptic Cd(II) Carboxylates

Synthesis, crystal structure, and in vitro biological evaluation of bismuth (III) complexes incorporating pyrazinohydrazide‐derived Schiff bases

Synthesis, Characterization, Biological Activity, and Topological Studies

Synthesis, Characterization,Computational Studies and Antimicrobial activity evaluation of Mixed ligand‐Metal complexes of selected thiosemicarbazones

Exploration of newly synthesized transition metal(II) complexes for infectious diseases

Synthesis, structural elucidation, molecular modeling and antimicrobial studies of Mn(II), Co(II), Ni(II), and Cu(II) complexes containing NO donor bidentate Schiff base

Synthesis via microwave irradiation, structural characterization, and antibacterial activities of new complexes of bismuth(III) with thiosemicarbazones

Structural behavior and surface layer modification of (E)-N'-((1H-indol-3-yl) methylene)-4-chlorobenzohydrazide: Spectroscopic, DFT, biomedical activity and molecular dynamic simulation against Candida Albicans receptor